Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Hematology
•
Hemostasis/Thrombosis
•
Neurology
•
Anticoagulation
What is your management approach in patients with severe Factor XI deficiency being considered for deep brain stimulation?
Related Questions
How do you approach the management of PFO in a young person with a cryptogenic CVA?
In a young female with severe osteoporosis due to congenital estrogen deficiency, can estrogen be prescribed if genetic testing for congenital disorders reveals a heterozygous Factor V Leiden mutation?
How long do you anticoagulate for cirrhosis patients who have portal vein thrombosis extending to the mesenteric veins?
In extremely obese patients with spontaneous DVT/PE who have been anticoagulated for > 6 months, do you feel comfortable reducing the DOAC to prophylactic dose or do you prefer continuing full dose indefinite anticoagulation?
Do you think that home INR monitoring is a feasible option for elderly, frail patients with atrial fibrillation on VKA treatment, given variations in socioeconomic status and access to care?
How would you manage a patient with new DVT while on dabigatran for atrial fibrillation who may have missed some doses of dabigatran around time of DVT?
Do you consider bleeding risk in elderly, frail patients with atrial fibrillation to be similar for all NOACs?
Would you change an elderly, frail patient with atrial fibrillation who is already on a NOAC to VKA treatment?
How would you manage a patient who develops acute stroke during neoadjuvant chemotherapy with KEYNOTE-522 for Stage III triple negative breast cancer?
How does your approach to subsegmental PE differ from segmental PE both diagnostically and therapeutically?
